Nephrology

A collaborative study between Mayo Clinic and the University of Illinois debunked the previous consensus about how kidney stones grow.

By Chris Bahnsen • June 1, 2021

Part II of this series shows how a breakthrough discovery about how kidney stones form may open the way for new, unorthodox treatments. The discovery was made possible by joining University of Illinois’ geology and biology forces with Mayo Clinic’s urology and nephrology expertise.

By Chris Bahnsen • June 1, 2021

In this month’s “Hot Topic,” Paul Jannetto, Ph.D. discusses the proper procedures for collecting and processing kidney stones in order to provide accurate, cost-effective analysis of patients’ kidney stones in a timely manner.

By MCL Education • November 4, 2019

Mayo Clinic researchers are tracking the familiar characteristics of kidney stone formers in an online prediction tool that could help sufferers anticipate if they'll experience future episodes.

By Mayo Clinic News Network • February 5, 2019

John Lieske, M.D., gives an overview of the phospholipase A2 receptor antibodies testing available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing improves upon previous testing approaches, and what clinical action can be taken due to the results of this testing.

By Alyssa Frank • January 18, 2019

This week’s Research Roundup highlights the evaluation of monoclonal gammopathy of renal significance: A consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

By Kelley Luedke • December 10, 2018

This week’s Research Roundup highlights predicting renal function outcomes after partial and radical nephrectomy.

By Kelley Luedke • December 3, 2018

This week’s Research Roundup highlights the clinical and pathology findings associated consistently with larger glomerular volume.

By Kelley Luedke • May 28, 2018

The National Kidney Foundation, the American Society for Clinical Pathology, and the nation’s leading laboratories and clinical laboratory societies have announced a new collaboration to remove barriers to testing for chronic kidney disease.

By Gina Chiri-Osmond • February 27, 2018

This week’s Research Roundup highlights how the DnaJ heat shock protein family B member 9 is a novel biomarker for fibrillary GN.

By Kelley Luedke • November 13, 2017

A team of Mayo Clinic pathologists have discovered a new tissue biomarker, DNAJB9, for fibrillary glomerulonephritis, a rare kidney disease of unknown pathogenesis and poor outlook—nearly half of all patients end up on dialysis within four years of diagnosis.

By Chris Bahnsen • October 17, 2017

This week’s Research Roundup highlights noninvasive assessment of renal fibrosis with magnetization transfer MR imaging.

By Kelley Luedke • June 12, 2017

Mayo Clinic neurologists, researchers, and a wide spectrum of allied health staff are in Boston for the 69th American Academy of Neurology Annual Meeting. Follow this blog for live updates from #AANAM as we attend the conference, mingle with colleagues at booth #685, and have a little fun. Have a comment or photo to share? [...]

By Mayo Clinic Laboratories • April 23, 2017